Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
JTO Clinical and Research Reports
|
August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC
William Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 22, 2025
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis
Adam Barsouk, Omar Elghawy, Alex Watts, et al.
Journal for Immunotherapy of Cancer
|
April 13, 2022
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
Charu Aggarwal, Amy Prawira, Scott Antonia, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis
Margaret Stalker, Connor B Grady, Alex Watts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers
Julie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Nature
|
March 8, 2019
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Jae W Lee, Meredith L Stone, Paige M Porrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020
David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Nature Medicine
|
February 6, 2024
Severe disease during both primary and secondary dengue virus infections in pediatric populations
Charu Aggarwal, Hasan Ahmed, Pragati Sharma, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
JTO Clinical and Research Reports
|
August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC
William Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 22, 2025
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis
Adam Barsouk, Omar Elghawy, Alex Watts, et al.
Journal for Immunotherapy of Cancer
|
April 13, 2022
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
Charu Aggarwal, Amy Prawira, Scott Antonia, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis
Margaret Stalker, Connor B Grady, Alex Watts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers
Julie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Nature
|
March 8, 2019
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Jae W Lee, Meredith L Stone, Paige M Porrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020
David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Nature Medicine
|
February 6, 2024
Severe disease during both primary and secondary dengue virus infections in pediatric populations
Charu Aggarwal, Hasan Ahmed, Pragati Sharma, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 17